Imiglitazar Uses, Dosage, Side Effects and more
Imiglitazar has been used in trials studying the treatment of Diabetes Mellitus.
| Attribute | Details |
|---|---|
| Trade Name | Imiglitazar |
| Generic | Imiglitazar |
| Imiglitazar Other Names | Imiglitazar |
| Type | |
| Formula | C28H26N2O5 |
| Weight | Average: 470.525 Monoisotopic: 470.184171945 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
